Kanola's Profile
Displaying 1751-1800 of 5146 result(s).
Go to page:
Recent Articles
- Cathie Wood's Bold Investment Moves: Key Stock Adjustments
- Snap Inc. Accused of Misleading Statements in Lawsuit
- Wanda L. James Unveils Congressional Campaign for Change
- Qlarant Joins Agile4Vets to Enhance Veteran Healthcare Services
- Qlarant Joins Forces to Transform Veteran Healthcare Services
- Sable Offshore faces investor lawsuit over production claims
- Coty's Stock Troubles: A Deeper Look into Retail Challenges
- AI Startup Born Secures $15 Million to Combat Loneliness
- Elcogen Unveils Cutting-Edge Manufacturing Facility for Clean Energy
- Trailblazer Merger Corporation I Reschedules Annual Meeting
- Understanding the Fluor Corporation Class Action Lawsuit Details
- Explore Artistic Possibilities with Wacom One 14 Pen Display
- Ubiqconn and RuggON Present Innovative Solutions at TADTE
- KT&G Showcases ESSE at Intertabac 2025 to Boost Global Reach
- Investors Concerns Over Fly-E Group, Inc. Amid Class Action
- Understanding Class Action Opportunities for Savara Investors
- Diversified Energy's Secondary Offering: Key Insights Ahead
- Cygnus Metals Boosts Resource Estimate in Copper-Gold Project
- V.F. Corporation Class Action Lawsuit: Key Information for Investors
- Diversified Energy's Recent Ordinary Shares Offering Explained
- Transforming Client Care: Emily Mehr's Role at Sweet James
- Beauty Power's Nail Care Set Wins Prestigious Beauty Award
- Former CIA Officer Discusses AI Project Impact on America
- Elliott Investment Management's Support for Workday's Future
- The Journey of a $1000 Microsoft Investment Over 20 Years
- Clorox Company Announces New Quarterly Dividend of $1.24
- Savara Inc. Investors Get Opportunity for Class Action Suit
- Investors Take Action in Lockheed Martin Securities Case
- Investigation Launch by Rosen Law for Encompass Health Investors
- Elliott Investment Management's Progressive Outlook on Workday
- Landmark Study Highlights NobleStitch™ PFO Closure Benefits
- Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
- Western Forest Products Secures New US$30 Million Credit Facility
- Western Forest Products Secures a New $30 Million Credit Facility
- Discover the Growth Potential of Progressive Investments
- Altimmune Investors Urged to Act Before Class Action Deadline
- Revolutionizing Storytelling: Verily Storyworks Emerges
- Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
- Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
- Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status
- Investors Stand United in LifeMD Securities Fraud Case
- Exciting Developments in StubHub's Initial Public Offering
- Brookfield Global Infrastructure Fund Declares Quarterly Dividend
- Fly-E Group Faces Important Class Action Deadline for Investors
- The Growth Journey of Dell Technologies Stock Over Five Years
- Veteran Author Fosters Community Connections Through Book Event
- Brookfield Announces Quarterly Distribution for Investors
- Launched Investigation into Lesaka Technologies for Shareholders
- Legal Guidance for CTO Realty Growth Investors Ahead of Deadline
- A Remarkable Journey: The Growth of Starbucks Over 20 Years
